Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001381046 | SCV001579298 | pathogenic | Holocarboxylase synthetase deficiency | 2022-11-28 | criteria provided, single submitter | clinical testing | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 1069237). This variant has not been reported in the literature in individuals affected with HLCS-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Thr477Glnfs*9) in the HLCS gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in HLCS are known to be pathogenic (PMID: 16134170). |
Baylor Genetics | RCV001381046 | SCV004199871 | likely pathogenic | Holocarboxylase synthetase deficiency | 2024-02-08 | criteria provided, single submitter | clinical testing |